Evolus, Inc.
EOLS
$0.02
Change (1 day)
$17.82
Year High
$9.80
Year Low
Categories
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Evolus, Inc. (EOLS) - Company Outlook
Company Outlook
| Year | Receivables | Debt | Liabilities | Assets | Current Assets |
|---|---|---|---|---|---|
| 2023 | 30.53 M | 63.71 M | 209.69 M | 189 M | 112.42 M |
| 2022 | 22.45 M | 19.28 M | 159.48 M | 177.98 M | 100.8 M |
| 2021 | 14.66 M | -71,513,000 | 175.61 M | 257.48 M | 178.8 M |
| 2020 | 9.68 M | 35.76 M | 282.03 M | 209.07 M | 127.61 M |
| 2019 | 10.66 M | -13,346,000 | 160.99 M | 240.44 M | 152.2 M |